First publication of the PRISM method from 2016. 102 cell lines were labeled with unique 24-nucleotide barcodes and used to screen 8400 compounds. BRD-7880 was identified as a potent and highly specific inhibitor of aurora kinases B and C.
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
